全文获取类型
收费全文 | 16034篇 |
免费 | 1088篇 |
国内免费 | 72篇 |
学科分类
医药卫生 | 17194篇 |
出版年
2023年 | 166篇 |
2022年 | 110篇 |
2021年 | 645篇 |
2020年 | 340篇 |
2019年 | 556篇 |
2018年 | 659篇 |
2017年 | 433篇 |
2016年 | 422篇 |
2015年 | 491篇 |
2014年 | 656篇 |
2013年 | 819篇 |
2012年 | 1243篇 |
2011年 | 1248篇 |
2010年 | 739篇 |
2009年 | 608篇 |
2008年 | 956篇 |
2007年 | 996篇 |
2006年 | 830篇 |
2005年 | 887篇 |
2004年 | 755篇 |
2003年 | 729篇 |
2002年 | 647篇 |
2001年 | 230篇 |
2000年 | 233篇 |
1999年 | 225篇 |
1998年 | 125篇 |
1997年 | 105篇 |
1996年 | 74篇 |
1995年 | 87篇 |
1994年 | 62篇 |
1993年 | 57篇 |
1992年 | 119篇 |
1991年 | 104篇 |
1990年 | 89篇 |
1989年 | 71篇 |
1988年 | 58篇 |
1987年 | 59篇 |
1986年 | 52篇 |
1985年 | 49篇 |
1984年 | 48篇 |
1983年 | 41篇 |
1982年 | 26篇 |
1981年 | 29篇 |
1980年 | 22篇 |
1979年 | 23篇 |
1977年 | 18篇 |
1974年 | 20篇 |
1973年 | 33篇 |
1972年 | 23篇 |
1971年 | 21篇 |
排序方式: 共有10000条查询结果,搜索用时 46 毫秒
1.
2.
Notfall + Rettungsmedizin - 相似文献
3.
4.
Jose M. Morales Jose Angel Martinez-Flores Manuel Serrano Maria José Castro Francisco Javier Alfaro Florencio García Miguel Angel Martínez Amado Andrés Esther González Manuel Praga Estela Paz-Artal Antonio Serrano 《Journal of the American Society of Nephrology : JASN》2015,26(3):735-745
In the current immunosuppressive therapy era, vessel thrombosis is the most common cause of early graft loss after renal transplantation. The prevalence of IgA anti–β2-glycoprotein I antibodies (IgA-aB2GPI-ab) in patients on dialysis is elevated (>30%), and these antibodies correlate with mortality and cardiovascular morbidity. To evaluate the effect of IgA-aB2GPI-ab in patients with transplants, we followed all patients transplanted from 2000 to 2002 in the Hospital 12 de Octubre prospectively for 10 years. Presence of IgA-aB2GPI-ab in pretransplant serum was examined retrospectively. Of 269 patients, 89 patients were positive for IgA-aB2GPI-ab (33%; group 1), and the remaining patients were negative (67%; group 2). Graft loss at 6 months post-transplant was significantly higher in group 1 (10 of 89 versus 3 of 180 patients in group 2; P=0.002). The most frequent cause of graft loss was thrombosis of the vessels, which was observed only in group 1 (8 of 10 versus 0 of 3 patients in group 2; P=0.04). Multivariate analysis showed that the presence of IgA-aB2GPI-ab was an independent risk factor for early graft loss (P=0.04) and delayed graft function (P=0.04). There were no significant differences regarding patient survival between the two groups. Graft survival was similar in both groups after 6 months. In conclusion, patients with pretransplant IgA-aB2GPI-ab have a high risk of early graft loss caused by thrombosis and a high risk of delayed graft function. Therefore, pretransplant IgA-aB2GPI-ab may have a detrimental effect on early clinical outcomes after renal transplantation. 相似文献
5.
6.
7.
8.
9.
Li Sun Zia Sadique Isabel dos-Santos-Silva Li Yang Rosa Legood 《International journal of cancer. Journal international du cancer》2019,144(10):2596-2604
In low and middle-income countries mammographic breast cancer screening is prohibitively expensive and a cheaper alternative option is to use ultrasound as the primary screening test. In 2009, China launched a breast cancer screening programme for rural women aged 35–64 years with clinical breast examination coupled with ultrasound as the primary tool. Our study aimed to analyse the cost-effectiveness of breast screening compared to no screening among Chinese rural women. We developed a Markov model to estimate the lifetime costs and effects for rural women aged 35 years from a societal perspective. Asymptomatic women in the intervention arm were screened every 3 years before age 64 years. Breast cancer in the non-screening arm can only be diagnosed on presentation of symptoms. Parameter uncertainty was explored using one-way and probabilistic sensitivity analyses. Compared to no screening, breast cancer screening cost $186.7 more and led to a loss of 0.20 quality-adjusted life years (QALYs). Breast screening was more expensive and did harm to health among rural women with an incremental cost-effectiveness ratio (ICER) of $-916/QALY. The sensitivity analysis identified utility loss from false positives as the factor that most influenced the results, but this did not affect the conclusions. In a rural setting with such low breast cancer incidence, screening for asymptomatic disease is not cost-effective with current screening tools. Priority should be given to ensure that symptomatic women have proper access to diagnosis and treatment at an early stage as this will lead to mortality reductions without the usual screening harms. 相似文献
10.